| Keywords: |
clinical trial; nonhuman; conference paper; methodology; neoplasm; neoplasms; antigen expression; animals; glycoprotein gp 100; cancer immunotherapy; tumor antigen; cancer research; immunology; antigens, neoplasm; cancer vaccine; cancer vaccines; tumor antigens; cancer testis antigen; melanoma antigen 1; cancer immunization; virus antigen; melan a; immunity; monophenol monooxygenase; immunological monitoring; immunosurveillance; clinical trials; monitoring, immunologic; differentiation antigen; cancer antibody; tumor immunology; cancer immunosurveillance; immunologic monitoring; antigen purification; humans; human; article
|
